Developing chemotherapy drugs against breast cancer is costly, slow, and often inefficient, with more than 95% of screened drug candidates failing in patient trials.
Colorado settles with two drug companies for $49 million in antitrust lawsuits – The Cannabist
Colorado will settle antitrust claims against two pharmaceutical companies for nearly $50 million as part of ongoing lawsuits that allege some of the country’s largest
November 2, 2024